This site is intended for health professionals only

Resource-carousel_canestan

Vulvovaginal candidiasis and bacterial vaginosis

Vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) are both common infections that are usually harmless and easily treated.1,2

VVC is estimated to affect up to three quarters of women during their reproductive life, with a greater susceptibility during pregnancy.3

Prevalence estimates for BV vary widely, from 5-50%.4 Untreated BV during pregnancy carries a small risk of late miscarriage and preterm delivery.2

References
1. NHS Choices. Thrush in men and women. https://www.nhs.uk/conditions/thrush-in-men-and-women/ Accessed August 2018
2. NHS Choices. Bacterial vaginosis. www.nhs.uk/conditions/ bacterial-vaginosis Accessed August 2018
3. Centers for Disease Control and Prevention (CDC). 2015 Sexually Transmitted Diseases Treatment Guidelines: Vulvovaginal candidiasis Available at: www.cdc.gov/std/ tg2015/candidiasis.htm Accessed August 2018
4. BASHH Guidelines: bacterial vaginosis. https://www.bashhguidelines.org/current-guidelines/vaginal-discharge/bacterial-vaginosis-2012/ Accessed August 2018

Useful links:
NHS Choices


For 40 years, Canesten has been helping women around the world understand and take control of their intimate health.

In this module, Canesten gives an overview of the main causes, signs, symptoms and treatment options for the two most common vaginal infections: vulvovaginal candidiasis and bacterial vaginosis. The article also provides an overview of the advice healthcare professionals can offer patients to promote the optimal use of medicines, along with strategies to help reduce the risk of recurrence.

https://www.canesten.co.uk/en/female/


Take our CPD module on vulvovaginal candidiasis and bacterial vaginosis

Vulvovaginal candidiasis and bacterial vaginosis